Independent Director · RAPT Therapeutics, Inc. (RAPT)

Wendye Robbins — RAPT Therapeutics Director Compensation (2024)

Fiscal year 2024 director compensation for Wendye Robbins at RAPT Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 14, 2025 (DEF 14A). Open the filing on EDGAR.

What they were paid

RAPT Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as RAPT Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$52,500$0$142,419$0$194,919

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RAPT Therapeutics, Inc. DEF 14A filed April 14, 2025, accession 0000950170-25-053517, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2024

RAPT Therapeutics pays directors a $40,000 cash retainer and $200,000 in Options.

Committees

FY2024 · as the proxy prints them

Audit

The rest of the RAPT Therapeutics board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Brian WongDirector$0
Linda KozickIndependent Director$191,919
Lori Lyons-WilliamsChair of the Board$194,294
Mary Ann GrayIndependent Director$207,419
Michael GiordanoIndependent Director$201,419

The full RAPT Therapeutics compensation record

free company brief

This page is one director within RAPT Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy